POZ
The Department of Health considers PLHIVs under “persons with comorbidities”; meaning they should be among priority people for COVID-19 vaccination. But PLHIVs still have...
Hi, what are you looking for?
SOGIE Equality Bill passes Senate committee; still in limbo due to anti-LGBTQIA senators
LGBTQIA people may designate partners as beneficiaries in insurance plans – Insurance Commission
Rainbow’s beginning
Supreme Court junks with finality petition for same-sex marriage
Inter-Agency Committee on Diversity and Inclusion created via executive order
PLHIVs should be included in COVID-19 vaccination priority, say advocates
Life-long antiviral treatment seems to prevent mother-to-baby HIV transmission
Researchers find diverse supportive partnerships among older gay men with and without HIV
Self-testing trebles HIV testing rate among trans people
Phl ends 2020 with 22 new HIV cases per day
The Department of Health considers PLHIVs under “persons with comorbidities”; meaning they should be among priority people for COVID-19 vaccination. But PLHIVs still have...
Anti-retroviral drugs are a vital tool in the prevention and treatment of HIV. Now a new study of pregnant women shows that life-long antiviral...
Along with successful HIV treatments, it is known that the presence of social support impacts long-term survival among men living with HIV. However, little...
Despite increased vulnerability for trans people, they are seldom included in HIV testing or prevention research, and when they are their data is rarely...
Discrimination can occur at all stages of criminal justice involvement, from differential enforcement and/or threats of violence by police officers to court proceedings and...
The government figures may not show the real situation because HIV-related services - including testing - have been affected by Covid-19.
Those belonging in minority sectors are greatly affected by Covid-19; more so than others. This is according to a study by Indiana University which...
New report provides update on trends in the region and outlines the problematic laws and policies that continue to impact people living with HIV...
The FDA in the US approved CABENUVA as the first once-monthly, long-acting injectable (LAI) for the treatment of HIV-1 infection in adults. CABENUVA consists...
